Research
Title : | Antibody-based capture of 2019-nCoV and its inactivation using lipid-based in situ gel |
Area of research : | COVID-19 Research, Life Sciences & Biotechnology, Pharmaceutical Sciences |
Focus area : | Drug repurposing for COVID-19 |
Principal Investigator : | Dr. Kiran Kondabagil, Associate Professor, Indian Institute of Technology (IIT), Mumbai |
Timeline Start Year : | 2020 |
Contact info : | kirankondabagil@iitb.ac.in |
Details
Executive Summary : | The project aims to develop antibodies against the receptor-binding domain of the spike glycoprotein of CoV involved in recognizing a host cell-surface receptor, namely, zinc peptidase angiotensin-converting enzyme 2. Another objective is to develop unsaturated free fatty acid-based emulsion loaded in-situ gels to inactivate the virus at the point of entry. |
Organizations involved
Implementing Agency : | Indian Institute of Technology (IIT), Mumbai Funding Agency :Science and Engineering Research Board (SERB), Department of Science and Technology (DST), New Delhi | |